key: cord-0781022-kolz1ew1
authors: Wallace, Adam N.; Asif, Kaiz S.; Sahlein, Daniel H.; Warach, Steven J.; Malisch, Timothy; LaFranchise, E. Francis; Geraghty, Scott; Kreitel, K. Derek; Lamonte, Marian P.; Miley, Jefferson T.; Gibson, Daniel P.; Amuluru, Krishna
title: Patient Characteristics and Outcomes Associated with Decline in Stroke Volumes during the Early COVID-19 Pandemic
date: 2020-12-26
journal: J Stroke Cerebrovasc Dis
DOI: 10.1016/j.jstrokecerebrovasdis.2020.105569
sha: b346f13d1e6c54ff4b0eabc1b4769807d92f1a92
doc_id: 781022
cord_uid: kolz1ew1

BACKGROUND AND PURPOSE: Delayed evaluation of stroke may contribute to COVID-19 pandemic-related morbidity and mortality. This study evaluated patient characteristics, process measures and outcomes associated with the decline in stroke presentation during the early pandemic. METHODS: Volumes of stroke presentations, intravenous thrombolytic administrations, and mechanical thrombectomies from 52 hospitals from January 1-June 30, 2020 were analyzed with piecewise linear regression and linear spline models. Univariate analysis compared pandemic (case) and control groups defined in relation to the nadir of daily strokes during the study period. Significantly different patient characteristics were further evaluated with logistic regression, and significantly different process measures and outcomes were re-analyzed after propensity score matching. RESULTS: Analysis of 7,389 patients found daily stroke volumes decreased 0.91/day from March 12-26 (P < 0.0001), reaching a nadir 35.0% less than expected, and increased 0.15 strokes/day from March 27 – June 23, 2020 (P < 0.0001). Thrombolytic administrations decreased 3.3/week from February 19-March 31 (P=0.0023), reaching a nadir 33.4% less than then expected, and increased 1.4 administrations/week from April 1-June 23 (P<0.0001). MT volumes decreased by 1.5/week from February 19-March 31, 2020 (P=0.0039), reaching a nadir 11.3% less than expected. The pandemic group had a higher rate of pre-stroke independent ambulation (P= 0.02, OR=1.60, 95% CI=1.08-2.42), and lower NIHSS on presentation (P=0.04, OR=1.01, 95% CI=1.00-1.02). Process measures and outcomes of each group did not differ, including door-to-needle time, door-to-puncture time, and successful mechanical thrombectomy rate. CONCLUSION: Stroke presentations and acute interventions decreased during the early COVID-19 pandemic, at least in part due to patients with milder symptoms and lower functional status not seeking medical care. Public health messaging and initiatives should target these populations.

Recent studies have documented a decrease in evaluations of stroke patients during the early weeks of the coronavirus disease 2019 (COVID-19) outbreak in the United States (US) [1] [2] [3] [4] . This phenomenon raises concern that delays in emergent treatment and implementation of secondary stroke prevention measures may contribute to the morbidity and mortality of the pandemic. As a second wave of COVID-19 sweeps through the country, there is an urgent need for public health communication that targets populations most likely to delay evaluation for stroke-like symptoms. The purpose of this study was to identify differences in stroke patient characteristics, process measures and outcomes corresponding with the decline in stroke presentations during the early weeks of the pandemic.

This is a retrospective case-control cohort analysis. This study was approved by our Institutional Review Board, which sanctioned a waiver of informed consent.

Ascension is the second largest health system in the US by hospital count. A total of 54 Ascension Table 1 . The data set for this study included patients presenting to these hospitals who received a primary diagnosis of stroke from January 1 -June 30, 2020, including patients transferred to an Ascension hospital from outside the network.

Data from January 1 -June 30, 2019 were also included to capture temporal variations in stroke volumes.

Scatterplot of the 7-day moving average of daily stroke volumes from January 1 -June 30, 2020 was visually analyzed for time cut-points corresponding to inflection points on the curve. Piecewise linear regression was used to quantify the change in daily stroke volumes between each time cut point. The daily stroke volume data were fit with a piecewise linear spline model, the nadir of which was compared with an "expected" daily volume generated from a cubic spline model fit to the 7-day moving average of daily stroke volumes from January 1 -June 30, 2019 (Supplemental Figure 1 ). To ensure this comparison was not confounded by workflow changes from 2019 to 2020, the nadir of 2020 daily stroke volumes was also compared with the mean daily volume from January 1 -February 29, 2020. These analyses were repeated for the 3-week moving averages of weekly intravenous tissue plasminogen activator (IV tPA) administrations and mechanical thrombectomies (MTs), except that expected 2020 MT volumes could not be estimated from 2019 data because MT volumes have steadily increased over the last 2 years within the network of hospitals included in this study.

Time-based subgroup cohorts were established to assess for differences in patient characteristics process measures, and outcomes associated with the decline in stroke volumes during the early pandemic. The control group comprised strokes from January -February 2020. We chose January -February 2020 as the prepandemic comparator epoch since it was most proximal to onset of the pandemic, and therefore least likely to be confounded by temporal changes in workflow or referral patterns. We confirmed that these months were representative of a prepandemic time by comparing patient characteristics during January -February 2020 with those from November -December 2019, which were all similar with the exception of patient history of hyperlipidemia (Supplemental Table 2 ).

The case or "pandemic" group was defined in relation to the time cut points identified by volume trend analysis as follows:

where ( ) = piecewise linear spline model of 2020 daily stroke volumes and ( ) = knot .

Patient characteristics used for patient-level analysis are listed in Table 1 . These data were extracted from our institutional stroke database. Median incomes of patients' residential zip codes were derived from publicly available government data 5 . Process measures and outcomes listed in Table 2 were extracted or calculated from data in the institutional stroke database. Emergency Department (ED) arrival and IV tPA administration times were not available for patients initially presenting to hospitals outside the network. Unknown last known well (LKW), ED arrival, and IV tPA administration times were considered missing and were not imputed.

Categorical and continuous variables are presented as N (%) and median (interquartile range), Process measures and outcomes that differed between the two subgroups (P < 0.10) were further compared using propensity score analysis. Propensity scores were generated from the following covariates: age, gender, race, hospital location (state, urban vs non-urban), comorbidities listed in Table   1 , pre-stroke independent ambulatory status, pre-admission anticoagulation and antiplatelet usage, LKW-to-emergency department (ED) arrival time, NIHSS on presentation, whether patient received IV tPA, and presence of large vessel occlusion. Propensity scores underwent 1:1 nearest neighbor (Greedytype) matching of the logit of the propensity score with a caliper width of 0.25. Matching was performed without replacement and unpaired pandemic and control patients not meeting matching criteria were excluded. Multiple control cases matching a single pandemic case were included in the matched data set and weighted accordingly. Covariate balance was assessed before and after matching using the  2 omnibus test described by Hansen and Bowers 7 and illustrated with split histograms. Outcomes were then compared between treatment and control propensity-matched patients using univariate statistics.

Statistics were performed using R version 4.0.3.

A total of 7,389 stroke patients presented from January 1 -June 30, 2020. Scatterplot visualization Table 5 ).

Process measures for each group are presented in Table 2 . LKW-to-ED arrival, door-to-needle time, door-to-puncture time, Thrombolysis in Cerebral Infarction (TICI) ≥2b recanalization rate, and length of stay did not differ between the pandemic and control groups. Univariate analysis showed a statistically significant difference between the two groups in terms of disposition (P<0.01). After excluding cases with missing data, 1,780 patients were used to generate 577 matches comprised of 1,419 unweighted observations. After propensity score matching, pandemic and control groups did not differ in terms of discharge home (P=0.48), discharge to home or acute rehab (P=0.36), or in-hospital mortality or discharge to hospice (P=0.48; Supplemental Figure 2 ).

Our analysis of stroke presentations to one of the largest hospital networks in the United States found a studies may be due to regional differences in fear of contracting COVID-19 at the hospital. Additionally, the larger sample size of our study allowed for detection of smaller statistical differences, as well as use of logistic regression to control for demographic and clinical covariates. Lastly, inclusion of more recent data allowed us to define the pandemic group in relation to the nadir of daily stroke volumes and exclude the initial decline and later recovery periods when patient characteristics may have more closely resembled those before the pandemic.

Another key finding of this study is that patients in the pandemic group were more likely to ambulate independently at baseline (95.2 vs 93.1%), a difference that remained statistically significant after logistic regression (P=0.02, OR=1.60, 95% CI=1.08-2.42). This finding raises concern that the social isolation caused by the pandemic is disproportionately impacting people with lower functional status. As Therefore, lack of IV tPA administration to acute ischemic stroke patients may be an important source of collateral morbidity associated with the COVID-19 pandemic and underscores the importance of informing the public that the potential benefits of time-sensitive stroke interventions far outweigh the risks of COVID-19 infection. Notably, our data suggest that the decrease in IV tPA administrations was primarily due to patients not seeking care at all, rather than arriving to the ED beyond the tPA window.

Although patients in the pandemic group had a longer mean LKW-to-ED arrival time (10.0 vs 9.2 hours, P=0.18), the difference was not statistically significant, which is consistent with other studies 16 .

In contrast with overall stroke and IV tPA administration volumes, our results showed a less pronounced decrease in MTs. The 3-week moving average of MT volumes decreased by only 1.5 MTs/week from February 19 -March 31, 2020, reaching a nadir that was only 11.3% less than the pre-pandemic mean.

Univariate analysis found a higher proportion of patients in the pandemic group with LVO (10.6 vs 8.5%, P=0.04), though the difference did not remain statistically significant after logistic regression. The most likely explanation is that patients with LVO also had higher NIHSS scores and were therefore less likely to forego emergent evaluation. However, approximately 10% of patients with mild stroke symptoms have a LVO 17 . Further research is needed to determine whether the decline in MT volumes was due to patients with LVO and mild symptoms not seeking medical care, and if so, the associated morbidity.

An important issue that remains unaddressed is the extent to which lack of acute medical care translated into inadequate secondary stroke prevention and rehabilitation. The cohort for this study only included patients discharged from our network of hospitals with a primary diagnosis of stroke.

Some patients who avoided presenting to the hospital may have sought outpatient care, particularly those with mild symptoms. However, since the risk of recurrent stroke is highest in the weeks following an initial event 18 , public health communications should urge patients that may not have initially sought medical care for mild or transient stroke symptoms to contact a healthcare professional for initiation of appropriate diagnostic testing, medical therapy and rehabilitation services to optimize functional recovery.

The added strain the pandemic has placed on our healthcare system has generated concern that treatment of other health emergencies may suffer. However, our study found no difference in process measures or outcomes before and after the pandemic, including door-to-needle and door-to-puncture times, successful MT reperfusion rates, and mortality rates. This is an encouraging sign that the infrastructure developed in recent years to quickly triage and deliver time-sensitive treatments to stroke patients can withstand the workflow disruptions caused by the pandemic.

In addition to its retrospective design, this study has other limitations to acknowledge. First, due to the broad scope of this study with inclusion of multiple hospitals, data were collected by multiple abstractors who may have interpreted abstraction guidelines differently. Also, some data elements were not routinely documented at every site or not available for patients transferred into our network. In particular, hospital arrival and door-to-needle times were only available for patients initially presenting within our network, so analyses including these process measures may have been biased by significant differences between patients initially presenting within versus outside our hospital network. Likewise, some process measure and outcome data were not available for patients transferred outside our network. Because propensity score matching requires a complete data set, missing data must either be imputed or patients with missing data elements must be excluded. We chose the latter approach to avoid introducing bias related to imputed data, and we used preadmission ambulatory status and disposition as surrogates for baseline and discharge mRS, respectively, because the former were more frequently documented. Second, regional variation in prevalence and timing of COVID-19 infections, as well as differing responses by state and local governments and populations to the pandemic, is a potential confounding variable. However, we found that the state in which a hospital was located did not influence our results. Other national studies similarly found no significant differences in regional pandemic-related volume trends 4 . This is likely because the spiking infection numbers in New York City and Seattle that overwhelmed local hospital capacities were widely reported via national media outlets.

Still, our results may not be generalizable to regions of the United States outside our hospital network.

Third, our analysis only included ED visits and hospital admissions and did not account for patients accessing healthcare in other ways, such as ambulatory clinics, urgent care, or virtual visits. Lastly, changes in practice and referral patterns may have changed between the case and control epochs of this study, as is always the case with temporal data.

Analysis of volume trends from one of the largest hospital networks in the United States showed decreased stroke presentations, IV tPA administrations, and MTs associated with the early COVID-19

pandemic. Patients with milder stroke symptoms and lower functional status were less likely to seek medical care during the early pandemic. Public health messaging and initiatives should target these populations to ensure they receive time-sensitive acute intervention, secondary stroke prevention, and rehabilitation. Stroke process measures such IV tPA door-to-needle and MT door-to-puncture times did not deteriorate during the pandemic. 

Stroke Code Presentations, Interventions, and Outcomes Before and During the COVID-19 Pandemic

Decline in stroke alerts and hospitalisations during the COVID-19 pandemic

Temporary Emergency Guidance to US Stroke Centers During the Coronavirus Disease 2019 (COVID-19) Pandemic

Collateral Effect of Covid-19 on Stroke Evaluation in the United States

Natural History, and Clinical Presentation of Large Vessel Ischemic Stroke

The Urban and Rural Classifications

Covariate Balance in Simple, Stratified and Clustered Comparative Studies

National Emergency Concerning the Novel Coronavirus Disease (COVID-19) Outbreak

Where have our patients gone? The impact of COVID-19 on stroke imaging and intervention at an Australian stroke center

Stroke care during the COVID-19 pandemic: experience from three large European countries

Impact of COVID-2019 on stroke services in China: survey from the Chinese Stroke Association. Stroke Vasc Neurol

Effect of COVID-19 pandemic on stroke admission rates in a Norwegian population

Short-term and long-term health impacts of air pollution reductions from COVID-19 lockdowns in China and Europe: a modelling study -The Lancet Planetary Health

Expected Health Effects of Reduced Air Pollution from COVID-19 Social Distancing

Decline in Stroke Presentations During COVID-19 Surge

Break in the Stroke Chain of Survival Due to COVID-19

Acute Neurological Deterioration in Large Vessel Occlusions and Mild Symptoms Managed Medically

Risk and cumulative risk of stroke recurrence: a systematic review and meta-analysis

Comparison of process measures and outcomes for control and pandemic groups. Categorical and continuous variables are presented as N (%) and median (interquartile range), respectively. Abbreviations: ED, emergency department; mRS, modified Rankin Scale